CD8A and neoplasm: In agreement with the increased CD8+ T cells in the peripheral blood of patients or mice with CRPC following tumors treated with ARPI plus IR (Figure 1G and Supplemental Figure 1F), we observed obvious abscopal effects of dual treatment on Myc-CaP tumor growth in the mice (Supplemental Figure 1, A–D).